Wu XR - Search Results

1

A survivin gene signature predicts aggressive tumor behavior.

Salz W, Eisenberg D, Plescia J, Garlick DS, Weiss RM, Wu XR, Sun TT, Altieri DC. Salz W, et al. Among authors: wu xr. Cancer Res. 2005 May 1;65(9):3531-4. doi: 10.1158/0008-5472.CAN-04-4284. Cancer Res. 2005. PMID: 15867343

2

Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.

Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT, Wu XR. Cheng J, et al. Among authors: wu xr. Cancer Res. 2002 Jul 15;62(14):4157-63. Cancer Res. 2002. PMID: 12124355

3

Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.

Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, Waldman FM, Wu XR. Cheng J, et al. Among authors: wu xr. Cancer Res. 2003 Jan 1;63(1):179-85. Cancer Res. 2003. PMID: 12517796

4

Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.

Garcia-España A, Salazar E, Sun TT, Wu XR, Pellicer A. Garcia-España A, et al. Among authors: wu xr. Cancer Res. 2005 Feb 15;65(4):1150-7. doi: 10.1158/0008-5472.CAN-04-2074. Cancer Res. 2005. PMID: 15734997

5

Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.

Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR. Zhang ZT, et al. Among authors: wu xr. Cancer Res. 1999 Jul 15;59(14):3512-7. Cancer Res. 1999. PMID: 10416618

6

Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.

He F, Mo L, Zheng XY, Hu C, Lepor H, Lee EY, Sun TT, Wu XR. He F, et al. Among authors: wu xr. Cancer Res. 2009 Dec 15;69(24):9413-21. doi: 10.1158/0008-5472.CAN-09-2158. Cancer Res. 2009. PMID: 19951992 Free PMC article.

7

PKM2 Is Essential for Bladder Cancer Growth and Maintenance.

Xia Y, Wang X, Liu Y, Shapiro E, Lepor H, Tang MS, Sun TT, Wu XR. Xia Y, et al. Among authors: wu xr. Cancer Res. 2022 Feb 15;82(4):571-585. doi: 10.1158/0008-5472.CAN-21-0403. Cancer Res. 2022. PMID: 34903602 Free PMC article.

8

Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.

Osman I, Kang M, Lee A, Deng FM, Polsky D, Mikhail M, Chang C, David DA, Mitra N, Wu XR, Sun TT, Bajorin DF. Osman I, et al. Among authors: wu xr. Int J Cancer. 2004 Oct 10;111(6):934-9. doi: 10.1002/ijc.20366. Int J Cancer. 2004. PMID: 15300806

9

Gene deletion in urothelium by specific expression of Cre recombinase.

Mo L, Cheng J, Lee EY, Sun TT, Wu XR. Mo L, et al. Among authors: wu xr. Am J Physiol Renal Physiol. 2005 Sep;289(3):F562-8. doi: 10.1152/ajprenal.00368.2004. Epub 2005 Apr 19. Am J Physiol Renal Physiol. 2005. PMID: 15840768 Free article.

10

Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.

Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. Wu RL, et al. Among authors: wu xr. Cancer Res. 1998 Mar 15;58(6):1291-7. Cancer Res. 1998. PMID: 9515818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters